PI
HZNP

PEAK6 Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

PEAK6 Investments’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-814
Closed -$85.9K – 4946
2023
Q1 		$88.8K Buy
+814
New +$90K ﹤0.01% 3568
2022
Q4 		– Sell
-11,607
Closed -$964K – 5581
2022
Q3 		$718K Buy
11,607
+2,301
+25% +$161K ﹤0.01% 2531
2022
Q2 		$742K Buy
+9,306
New +$881K ﹤0.01% 3381
2021
Q2 		– Sell
-9,114
Closed -$839K – 6149
2021
Q1 		$839K Buy
+9,114
New +$769K ﹤0.01% 2720

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

PEAK6 Investments's HZNP Position: Q2 2023 in Review

PEAK6 Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 814 shares — an estimated $85.9K sold.

PEAK6 Investments first reported a position in HZNP in Q1 2021 and held it in 4 quarters. The position peaked at $839K in Q1 2021. 519 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

  • PEAK6 Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
  • PEAK6 Investments sold 814 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $85.9K.
  • PEAK6 Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 4 quarters.
  • PEAK6 Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $839K in Q1 2021.
  • 519 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on PEAK6 Investments's 13F filing for Q2 2023, filed 11 Aug 2023.